Growth Metrics

Enanta Pharmaceuticals (ENTA) Cash from Operations Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 19.63%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.63%
Dec 31, 2025 31.02%
Sep 30, 2025 25.25%
Jun 30, 2025 37.35%
Mar 31, 2025 20.03%
Dec 31, 2024 -8.18%
Sep 30, 2024 20.91%
Jun 30, 2024 20.59%
Mar 31, 2024 -84.16%
Dec 31, 2023 -18.84%
Sep 30, 2023 -11.79%
Jun 30, 2023 -92.73%
Mar 31, 2023 -43.25%
Dec 31, 2022 -69.65%
Sep 30, 2022 -56.29%
Jun 30, 2022 -139.20%
Mar 31, 2022 -42.22%
Dec 31, 2021 -34.60%
Sep 30, 2021 -39.96%
Jun 30, 2021 -110.21%
Mar 31, 2021 15.46%
Dec 31, 2020 -75.19%
Sep 30, 2020 -31.42%
Jun 30, 2020 2.19%
Mar 31, 2020 90.27%
Dec 31, 2019 57.82%
Sep 30, 2019 81.91%
Jun 30, 2019 47.35%
Mar 31, 2019 44.10%
Dec 31, 2018 0.29%
Sep 30, 2018 140.63%
Jun 30, 2018 31.71%
Mar 31, 2018 -27.58%
Dec 31, 2017 40.71%
Sep 30, 2017 138.81%
Jun 30, 2017 -28.80%
Mar 31, 2017 10.09%
Dec 31, 2016 36.36%
Sep 30, 2016 5.30%
Jun 30, 2016 29.08%
Mar 31, 2016 0.07%
Dec 31, 2015 49.12%
Sep 30, 2015 -11.75%
Jun 30, 2015 -54.81%